Advent International to acquire a significant stake in Suven Pharmaceuticals
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country
The product is backed by required scientific proof and comparative bioequivalence studies
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
They also released the Operational Guidelines for Wellness activities at AB-HWCs
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
The company sees the business reaching $100mn
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Subscribe To Our Newsletter & Stay Updated